We go back to the 1950s to find out how one of our scientists helped transform the outlook for women with a rare cancer called choriocarcinoma.
NHS behind on waiting times, childhood obesity, golden drugs showing promise, and… at-home genetic tests? Here’s our weekly news digest.
In part 4 of our radiotherapy series we look at MRI-guided radiotherapy, and how it could help improve accuracy and reduce side effects.
Read Alfred’s story of joining the STAMPEDE clinical trial. His is one of the many stories featured in our 2016/17 Annual Review.
New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.
Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.
We take a look at results from the STAMPEDE clinical trial, which is researching how to improve treatment for men with prostate cancer.